Related Experiment Video
Updated: Dec 20, 2025

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Time course of coronary flow capacity impairment in ST-segment elevation myocardial infarction
Martijn A van Lavieren1, Valérie E Stegehuis1, Matthijs Bax2
1Amsterdam University Medical Centres - location AMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, The Netherlands.
Insights
Microvascular dysfunction is key in ST-elevated myocardial infarction (STEMI) outcomes. Coronary flow capacity (CFC) improves over time in both culprit and non-culprit vessels after STEMI, aiding risk assessment.
Area of Science:
- Cardiology
- Vascular Biology
- Diagnostic Imaging
Background:
- Microvascular dysfunction significantly impacts long-term outcomes in ST-elevated myocardial infarction (STEMI).
- Coronary flow reserve (CFR) and coronary flow capacity (CFC) are established measures of coronary microcirculation and prognostic indicators in ischemic heart disease.
Purpose of the Study:
- To investigate the temporal changes in microcirculatory function using CFR and CFC in STEMI patients.
- To correlate microcirculatory parameters with clinical and biochemical markers in the acute phase and during follow-up.
Main Methods:
- Prospective assessment of CFR and CFC in culprit and non-culprit coronary vessels.
- Measurements were taken at baseline, one-week, and six-month follow-up in 98 STEMI patients.
Main Results:
- Culprit CFC showed trends related to infarct size, reperfusion time, and final TIMI flow.
- Non-culprit CFC correlated with C-reactive protein, peak troponin T, and heart rate.
- CFC significantly improved in both vessel types by one-week and six-month follow-up compared to baseline.
Conclusions:
- Microcirculatory disturbances are crucial in STEMI and affect diagnostic interpretations.
- Assessing non-culprit vessel CFC in STEMI may enhance risk stratification post-reperfusion.
Background:
Microvascular dysfunction in the setting of ST-elevated myocardial infarction (STEMI) plays an important role in long-term poor clinical outcome. Coronary flow reserve (CFR) is a well-established physiological parameter to interrogate the coronary microcirculation. Together with hyperaemic average peak flow velocity, CFR constitutes the coronary flow capacity (CFC), a validated risk stratification tool in ischaemic heart disease with significant prognostic value. This mechanistic study aims to elucidate the time course of the microcirculation as reflected by alterations in microcirculatory physiological parameters in the acute phase and during follow-up in STEMI patients.
Methods:
We assessed CFR and CFC in the culprit and non-culprit vessel in consecutive STEMI patients at baseline (n = 98) and after one-week (n = 64) and six-month follow-up (n = 65).
Results:
A significant trend for culprit CFC in infarct size as determined by peak troponin T (p = 0.004), time to reperfusion (p = 0.038), the incidence of final Thrombolysis In Myocardial Infarction 3 flow (p = 0.019) and systolic retrograde flow (p = 0.043) was observed. Non-culprit CFC linear contrast analysis revealed a significant trend in C-reactive protein (p = 0.027), peak troponin T (p < 0.001) and heart rate (p = 0.049). CFC improved both in the culprit and the non-culprit vessel at one-week (both p < 0.001) and six-month follow-up (p = 0.0013 and p < 0.001) compared with baseline.
Conclusion:
This study demonstrates the importance of microcirculatory disturbances in the setting of STEMI, which is relevant for the interpretation of intracoronary diagnostic techniques which are influenced by both culprit and non-culprit vascular territories. Assessment of non-culprit vessel CFC in the setting of STEMI might improve risk stratification of these patients following coronary reperfusion of the culprit vessel.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

